CESANO ALESSANDRA sold 52.3% of their position (62.15K shares) of PUMA BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $567.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/17/2026ACC: 0001437749-26-030593
Director
Since Jul 2022
-62.15K
Net shares
Net seller
$567.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
50K acquired · 112.15K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+50K
Price / share
$2.93
Trade value
$146.50K
% of position
72.6%
9/14/2026
68.85K→118.85K
Common Stock
Direct
Shares
−62.15K
Price / share
$9.12
Trade value
$566.99K
% of position
52.3%
9/14/2026
118.85K→56.70K
Total
Net shares
−12.15K
Net value
-$420.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/14/2026 | M · Option Exercise | +50K | $2.93 | $146.50K | 72.6% | 68.85K | 118.85K |
| Common Stock Direct | 9/14/2026 | S · Sale | −62.15K | $9.12 | $566.99K | 52.3% | 118.85K | 56.70K |
| Total | −12.15K | -$420.49K | ||||||
Derivative Transactions1
Stock Option
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
2.93
Held after
50K
Exercisable
—
9/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock50K shares | 9/14/2026 | M · Option Exercise | −50K | 2.93 | — | 50K |